Annual Working Capital
$159.15 M
-$130.76 M-45.10%
31 December 2023
Summary:
Century Therapeutics annual working capital is currently $159.15 million, with the most recent change of -$130.76 million (-45.10%) on 31 December 2023. During the last 3 years, it has risen by +$92.46 million (+138.66%). IPSC annual working capital is now -45.10% below its all-time high of $289.90 million, reached on 31 December 2022.IPSC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$186.19 M
+$1.87 M+1.02%
30 September 2024
Summary:
Century Therapeutics quarterly working capital is currently $186.19 million, with the most recent change of +$1.87 million (+1.02%) on 30 September 2024. Over the past year, it has increased by +$32.92 million (+21.48%). IPSC quarterly working capital is now -51.18% below its all-time high of $381.39 million, reached on 30 June 2021.IPSC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.1% | +21.5% |
| 3 y3 years | +138.7% | -33.6% |
| 5 y5 years | - | - |
IPSC Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.1% | +138.7% | -48.6% | +31.0% |
| 5 y | 5 years | -45.1% | +138.7% | -51.2% | +179.2% |
| alltime | all time | -45.1% | +138.7% | -51.2% | +179.2% |
Century Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $186.19 M(+1.0%) |
| June 2024 | - | $184.31 M(+0.3%) |
| Mar 2024 | - | $183.75 M(+15.5%) |
| Dec 2023 | $159.15 M(-45.1%) | $159.15 M(+3.8%) |
| Sept 2023 | - | $153.27 M(+7.8%) |
| June 2023 | - | $142.12 M(-37.7%) |
| Mar 2023 | - | $228.25 M(-21.3%) |
| Dec 2022 | $289.90 M | $289.90 M(-13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $334.73 M(-7.6%) |
| June 2022 | - | $362.22 M(+5.5%) |
| Mar 2022 | - | $343.29 M(+61.5%) |
| Dec 2021 | $212.50 M(+218.7%) | $212.50 M(-24.3%) |
| Sept 2021 | - | $280.53 M(-26.4%) |
| June 2021 | - | $381.39 M(+121.2%) |
| Mar 2021 | - | $172.39 M(+158.5%) |
| Dec 2020 | $66.69 M(-17.8%) | $66.69 M |
| Dec 2019 | $81.13 M | - |
FAQ
- What is Century Therapeutics annual working capital?
- What is the all time high annual working capital for Century Therapeutics?
- What is Century Therapeutics annual working capital year-on-year change?
- What is Century Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Century Therapeutics?
- What is Century Therapeutics quarterly working capital year-on-year change?
What is Century Therapeutics annual working capital?
The current annual working capital of IPSC is $159.15 M
What is the all time high annual working capital for Century Therapeutics?
Century Therapeutics all-time high annual working capital is $289.90 M
What is Century Therapeutics annual working capital year-on-year change?
Over the past year, IPSC annual working capital has changed by -$130.76 M (-45.10%)
What is Century Therapeutics quarterly working capital?
The current quarterly working capital of IPSC is $186.19 M
What is the all time high quarterly working capital for Century Therapeutics?
Century Therapeutics all-time high quarterly working capital is $381.39 M
What is Century Therapeutics quarterly working capital year-on-year change?
Over the past year, IPSC quarterly working capital has changed by +$32.92 M (+21.48%)